Cardinal Health, Inc. (NYSE:CAH) Shares Sold by Trust Co. of Vermont

Trust Co. of Vermont reduced its holdings in shares of Cardinal Health, Inc. (NYSE:CAH) by 4.9% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 5,039 shares of the company’s stock after selling 258 shares during the period. Trust Co. of Vermont’s holdings in Cardinal Health were worth $596,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in CAH. Geode Capital Management LLC lifted its stake in shares of Cardinal Health by 0.7% during the third quarter. Geode Capital Management LLC now owns 5,749,859 shares of the company’s stock worth $633,298,000 after buying an additional 42,082 shares during the period. CHURCHILL MANAGEMENT Corp raised its stake in Cardinal Health by 1.5% in the 4th quarter. CHURCHILL MANAGEMENT Corp now owns 240,422 shares of the company’s stock worth $28,435,000 after acquiring an additional 3,576 shares during the last quarter. Charles Schwab Investment Management Inc. lifted its position in Cardinal Health by 2.3% during the 3rd quarter. Charles Schwab Investment Management Inc. now owns 1,474,625 shares of the company’s stock worth $162,976,000 after acquiring an additional 33,388 shares during the period. Alpha Cubed Investments LLC purchased a new stake in Cardinal Health during the 3rd quarter valued at about $371,000. Finally, Healthcare of Ontario Pension Plan Trust Fund acquired a new position in shares of Cardinal Health in the third quarter valued at about $1,691,000. 87.17% of the stock is currently owned by hedge funds and other institutional investors.

Cardinal Health Stock Performance

Cardinal Health stock opened at $126.27 on Friday. The stock has a market capitalization of $30.56 billion, a P/E ratio of 24.57, a P/E/G ratio of 1.48 and a beta of 0.63. The company’s fifty day moving average price is $120.75 and its 200 day moving average price is $111.92. Cardinal Health, Inc. has a 1 year low of $93.17 and a 1 year high of $127.27.

Cardinal Health (NYSE:CAH) last released its earnings results on Friday, November 1st. The company reported $1.88 EPS for the quarter, topping analysts’ consensus estimates of $1.62 by $0.26. The business had revenue of $52.28 billion during the quarter, compared to analysts’ expectations of $50.90 billion. Cardinal Health had a net margin of 0.56% and a negative return on equity of 56.56%. The company’s quarterly revenue was down 4.3% on a year-over-year basis. During the same quarter in the previous year, the company earned $1.73 earnings per share. Sell-side analysts predict that Cardinal Health, Inc. will post 7.82 EPS for the current year.

Cardinal Health Cuts Dividend

The company also recently announced a quarterly dividend, which was paid on Wednesday, January 15th. Stockholders of record on Thursday, January 2nd were given a $0.5056 dividend. The ex-dividend date was Thursday, January 2nd. This represents a $2.02 annualized dividend and a dividend yield of 1.60%. Cardinal Health’s dividend payout ratio (DPR) is presently 39.30%.

Wall Street Analysts Forecast Growth

CAH has been the topic of a number of recent research reports. Citigroup upped their target price on Cardinal Health from $120.00 to $129.00 and gave the company a “neutral” rating in a research report on Friday, January 10th. Evercore ISI upgraded shares of Cardinal Health from an “in-line” rating to an “outperform” rating and set a $140.00 price objective on the stock in a research note on Tuesday, January 7th. Wells Fargo & Company raised shares of Cardinal Health from an “underweight” rating to an “equal weight” rating and upped their price target for the company from $101.00 to $127.00 in a report on Friday, December 13th. TD Cowen upgraded Cardinal Health from a “hold” rating to a “buy” rating and lifted their price objective for the company from $130.00 to $144.00 in a research note on Wednesday, January 8th. Finally, Deutsche Bank Aktiengesellschaft upped their target price on Cardinal Health from $119.00 to $124.00 and gave the stock a “hold” rating in a research note on Monday, November 4th. Four research analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average target price of $133.29.

About Cardinal Health

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.